Machine Learning and Social Network Analysis Applied to Alzheimer’s Disease Biomarkers

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|13|5|652-662

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.13, Iss.5, 2013-03, pp. : 652-662

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the nerve growth factor network in Alzheimer’s disease

By Sykiotis Gerasimos P   Papavassiliou Athanasios G  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 267-269

Informa Healthcare

Access to resources Recommend Favorite

Alzheimer’s Disease

By  

Cells Tissues Organs, Vol. 162, Iss. 1, 1998-10 ,pp. : 46-55

Karger

Access to resources Recommend Favorite

Health Utilities in Alzheimer’s Disease and Implications for Cost-Effectiveness Analysis

By Neumann Peter J.  

PharmacoEconomics, Vol. 23, Iss. 6, 2005-01 ,pp. : 537-541

Adis International

Access to resources Recommend Favorite

Strength and Weaknesses of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease and Possible Detection of Overlaps with Frailty Process

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 4, 2013-06 ,pp. : 538-546

Bentham Science Publishers

Access to resources Recommend Favorite

Subcellular Injuries in Alzheimer’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 4, 2014-06 ,pp. : 593-605

Bentham Science Publishers

Access to resources Recommend Favorite